Aurobindo Pharma
AUROPHARMA.NS
12,57 €
Share price
-0.32%
Change (1 day)
1.62%
Change (1 year)
Categories
Revenue for Aurobindo Pharma (AUROPHARMA.NS)
Revenue in 2024 (TTM): €3.36 Billion
According to Aurobindo Pharma
's latest financial reports the company's current revenue (TTM 
) is €3.35 Billion. an increase over the revenue in the year 2023 that were of €3.01 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Aurobindo Pharma from 2012 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | €3.48 B | 15.43% |
| 2023 | €3.01 B | 7.4% |
| 2022 | €2.81 B | 0.14% |
| 2021 | €2.80 B | 4.4% |
| 2020 | €2.68 B | -2.4% |
| 2019 | €2.75 B | 19.47% |
| 2018 | €2.30 B | 11.2% |
| 2017 | €2.07 B | -3.61% |
| 2016 | €2.15 B | 14.8% |
| 2015 | €1.87 B | 24.44% |
| 2014 | €1.50 B | 71.21% |
| 2013 | €0.87 B | 15.31% |
| 2012 | €0.76 B |